The ProcartaPlex 4-Plex panel for human cell death facilitates cancer research by analyzing four protein targets involved in cell death using Luminex xMAP technology. Many different types of deaths...
The ProcartaPlex 4-Plex panel for human cell death facilitates cancer research by analyzing four protein targets involved in cell death using Luminex xMAP technology. Many different types of regulated cell deaths have recently been described in addition to l ́apoptosis and necroptosis, namely: pyroptosis, parthanatos, autophagy, ferroptosis, netosis and immunogenic cell death, emphasizing the importance of resistance to cell death as a distinctive sign of cancer.
This panel holds important marker proteins involved in cell death. Hazard-associated molecular models (DAMPs) are released following cell stress (HSP70, HSP90) and play an important role in cancer development, as well as in response to cancer treatment and immunogenic cell death (HMGB1). In addition, DKK1, a secreted protein to regulate cell survival via the WNT signaling pathway, is included in the panel.
The panel is supplied in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X, requiring less pipeting and experimental configuration. It cannot be associated with simplexes or other panels. The biomarkers of this panel complement those of the Apoptotic Cell Clearance Panel ProcartaPlex (ref. EPX120-15218-901) targeting serum- and plasma-soluble proteins and the 6-Plex ProcartaPlex panel (ref. EPX06A-15823-901) targeting proteins in cell lysates.
ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy. The multiplex panels ProcartaPlex are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine) and are supplied with the reagents necessary to perform the assay.
Target list [microbille region]: Dkk-1 [27], HMGB1 (HMG-1) [51] HSP70 [29], HSP90 [56]
About ProcartaPlex strengths for Luminex platform
ProcartaPlex immunoassays are based on the principles of a sandwich ELISA, using two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all target proteins using a Luminex instrument. ProcartaPlex multiplex assays require only 25 µl plasma or serum or 50 µl cell culture supernatant and only four hours to obtain the analyzed results.
• Reproducible and reliable results — validated in panel according to the highest industry standard, including tests for protein target combinationability and cross-reactivity
• Plus of results per sample — simultaneously measure several protein targets in a single sample of 25 - 50 µL
• Well established Luminex technology highly referenced multiplexing platform for protein detection and quantification
ProcartaPlex assays use Luminex xMAP (multianalyte profiling) technology for simultaneous detection and quantification of up to 80 protein targets in a single 25–50 µL sample — in plasma, serum, cell culture supernatant and other body fluids.
Luminex MagPlex superparamagnetic microspheres in ProcartaPlex are coloured internally with precise proportions of red and infrared fluorophores to create 100 unique signatures that can be identified by Luminex xMAP detection systems (Luminex 200, FLEXMAP 3D and MAGPIX systems). Like the ELISA sandwich assay, ProcartaPlex uses paired antibody pairs to identify the protein of interest. In multiplexed assays, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). The combination of specific antibodies from a protein to a separate microbead allows for the analysis of several targets in a single well.
The most significant difference between a ProcartaPlex assay and a ELISA assay is that the ProcartaPlex capture antibody is combined with a magnetic microbead and is not adsorbed by any of the microplate wells. Thus, ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample. It takes them as long as they do a traditional ELISA sandwich.
ProcartaPlex multiplex panels are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine).